Cargando…
Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
Sulfasalazine has long been used for the treatment of rheumatoid arthritis and is often chosen as a first-line treatment. Here, we report a case of sulfasalazine-induced autoimmune thrombocytopenia and review the mechanisms behind drug-induced immune thrombocytopenia (DITP) and the approach to its d...
Autores principales: | Narayan, Nehal, Rigby, Shirley, Carlucci, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290041/ https://www.ncbi.nlm.nih.gov/pubmed/27778097 http://dx.doi.org/10.1007/s10067-016-3420-9 |
Ejemplares similares
-
Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis
por: Quallich, Leonard G, et al.
Publicado: (2001) -
Rheumatoid arthritis with pachymeningitis – a case presentation and review of the literature
por: Joshi, Sanyukta, et al.
Publicado: (2020) -
Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
por: Giraud, C., et al.
Publicado: (2016) -
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
por: Cai, Shaozhe, et al.
Publicado: (2020) -
COVID-19 in rheumatoid arthritis cases: an Iranian referral center experience
por: Shadmanfar, Soraya, et al.
Publicado: (2020)